Atlas Trials

OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol.

Clinical trial NCT07592260 · RECRUITING

Trial details

NCT number
NCT07592260
Sponsor
Alliance for International Medical Action
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Malnutrition SevereVaccination
Start date
2025-05-01
Primary completion
2026-12-01
Enrollment
20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.